Bile Proteomic Profiles Differentiate Cholangiocarcinoma From Primary Sclerosing Cholangitis and Choledocholithiasis §Δ

2010161 citationsJournal Articlehybrid Open Access

Authors

Tim O. Lankisch · Medizinische Hochschule Hannover

Jochen Metzger · Mosaiques Diagnostics and Therapeutics (Germany)

Ahmed Negm · Medizinische Hochschule Hannover

Katja Voβkuhl · Medizinische Hochschule Hannover

Eric Schiffer · Mosaiques Diagnostics and Therapeutics (Germany)

Justyna Siwy · Mosaiques Diagnostics and Therapeutics (Germany)

Tobias J. Weismüller

Abstract

Bile proteomic analysis discriminates benign conditions from CC accurately. This method may become a diagnostic tool in future as it offers a new possibility to diagnose malignant bile duct disease and thus enables efficient therapy particularly in patients with PSC.

Topics & Keywords

Cholangiocarcinoma and Gallbladder Cancer Studies Liver Diseases and Immunity Hepatitis B Virus Studies

UN Sustainable Development Goals

Reduced inequalities

Publication Details

Published in: Hepatology

Volume 53, Issue 3, pp. 875-884

DOI: 10.1002/hep.24103

Field-Weighted Citation Impact: 12.75